The history of Viagra and its originator, copyright, presents a complex picture for prospective investors. While the revolutionary drug initially fueled enormous profits , its patent has ended, leading to competing options flooding the market . This reduction in cost presents a real challenge for copyright and any fund considering a heavy positi… Read More